The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Hims & Hers Health Inc (NYSE: HIMS) was $28.09 for the day, down -0.18% from the previous closing price of $28.14. In other words, the price has decreased by -$0.18 from its previous closing price. On the day, 13.69 million shares were traded.
Ratios:
Our analysis of HIMS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.47. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on February 18, 2025, Downgraded its rating to Equal-Weight and sets its target price to $60 from $42 previously.
On January 10, 2025, Citigroup Downgraded its rating to Sell which previously was Neutral and also upped its target price recommendation from $24 to $25.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on January 07, 2025, with a $35 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 21 ’25 when Baird Melissa sold 33,333 shares for $25.78 per share. The transaction valued at 859,256 led to the insider holds 805,083 shares of the business.
Becklund Irene sold 2,936 shares of HIMS for $77,775 on Apr 22 ’25. The PAO now owns 5,071 shares after completing the transaction at $26.49 per share. On Apr 22 ’25, another insider, Becklund Irene, who serves as the Officer of the company, bought 2,936 shares for $26.49 each.
Valuation Measures:
As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 52.52, and their Forward P/E ratio for the next fiscal year is 31.80. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.23 while its Price-to-Book (P/B) ratio in mrq is 13.01.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -22.32%, while the 200-Day Moving Average is calculated to be 5.31%.
Shares Statistics:
A total of 212.46M shares are outstanding, with a floating share count of 182.08M. Insiders hold about 18.04% of the company’s shares, while institutions hold 74.22% stake in the company.
